GENEVA, Nov. 4 -- INCREGEN THERAPEUTICS LLC (143 Bennett Avenue, 5JNew York, NY 10040) filed a patent application (PCT/US2024/062410) for "FC-NULL ANTI-GIP ANTIBODIES" on Dec 31, 2024. With publication no. WO/2025/226312, the details related to the patent application was published on Oct 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GRIFFIN, Patrick, H. (143 Bennett Avenue, 5JNew York, NY 10040), TAN, Philip (143 Bennett Avenue, 5JNew York, NY 10040)
Abstract: The disclosure provides Fc polypeptides wherein the Fc domain comprises at least one amino acid substitution that reduces bind...